{'fraction_non_alphanumeric': 0.019253910950661854, 'fraction_numerical': 0.009626955475330927, 'mean_word_length': 5.208955223880597, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Integrative Approaches to Multiple Sclerosis

Multiple sclerosis (MS) is a chronic progressive autoimmune disorder specific to the central nervous system. The incidence of MS in the United States is roughly 400,000 cases, and worldwide there are approximately 2.5 million cases. It is one of the more common neurodegenerative disease and is thought to be autoimmune, although an antibody has not yet been identified. The current standard of treatment consists of disease-modifying drugs, which have their own toxicity profiles that can inflict further harm to a patient. Indeed, many patients are wary of initiating or continuing this type of treatment. Many patients include alternative treatment approaches. This chapter reviews an integrative approach based on our understanding of the disease and the current state of evidence.